United Kingdom

People: PTC Therapeutics Inc (PTCT.OQ)

PTCT.OQ on NASDAQ Stock Exchange Global Select Market

20 Jul 2018
Change (% chg)

$3.43 (+9.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Almstead, Neil 

Dr. Neil Almstead Ph.D. is Executive Vice President, Research, Pharmaceutical Operations & Technology of PTC Therapeutics Inc. Dr. Almstead has been employed with PTC since 2000. He served as our Senior Vice President, Research and CMC from July 2008 to December 2014 and Senior Vice President, Chemistry and CMC from January 2007 to June 2008. Prior to joining PTC, Dr. Almstead served as Project Manager at Procter & Gamble Company, a publicly traded consumer products company. Dr. Almstead has co-authored more than 75 publications and patents pertaining to the design and synthesis of lead candidate compounds for genetic disorders, oncology and inflammatory diseases. Dr. Almstead received a B.S. from Clarkson University and a Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign.

Basic Compensation

Total Annual Compensation, USD 565,882
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,062,970
Fiscal Year Total, USD 1,628,850

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --